Literature DB >> 9396955

Premenstrual syndrome: evidence for symptom stability across cycles.

M Bloch1, P J Schmidt, D R Rubinow.   

Abstract

OBJECTIVE: This study assessed cycle to cycle symptom stability in women with premenstrual syndrome (PMS).
METHOD: Symptom ratings obtained prospectively over three or more symptomatic cycles from 16 women with PMS were analyzed. Measures of symptom severity and change were used to generate a coefficient of variation and an intraclass correlation coefficient (ICC) for each one of 14 symptoms across all cycles. In addition, symptoms were divided into three clusters, and the stability of the rank order of severity of symptoms within clusters and the correlation between symptom clusters were also calculated.
RESULTS: In the 65 cycles studied, mood symptoms were the most prevalent. Mood symptoms--anxiety, irritability, and mood lability--had the lowest coefficients of variation but also the lowest ICCs of all symptoms. Within their respective symptom clusters, both physical and mood symptoms showed remarkable stability across cycles of their rank order of severity, but only the mood symptom cluster was highly correlated with functional impairment.
CONCLUSIONS: Three mood symptoms--anxiety, irritability, and mood lability--were the most stable symptoms in this group of women with PMS. Mood and not somatic symptoms accounted for most of the functional impairment in this group of women. It is concluded that PMS is a stable syndrome that may best be viewed as part of the spectrum of recurrent mood disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9396955     DOI: 10.1176/ajp.154.12.1741

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

1.  Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone.

Authors:  Tory A Eisenlohr-Moul; C Nathan DeWall; Susan S Girdler; Suzanne C Segerstrom
Journal:  Biol Psychol       Date:  2015-03-30       Impact factor: 3.251

2.  Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial.

Authors:  Tory A Eisenlohr-Moul; Susan S Girdler; Jacqueline L Johnson; Peter J Schmidt; David R Rubinow
Journal:  Depress Anxiety       Date:  2017-07-17       Impact factor: 6.505

3.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

4.  Prolonged menstrual cycles in female workers exposed to ethylene glycol ethers in the semiconductor manufacturing industry.

Authors:  G-Y Hsieh; J-D Wang; T-J Cheng; P-C Chen
Journal:  Occup Environ Med       Date:  2005-08       Impact factor: 4.402

5.  The influence of early life sexual abuse on oxytocin concentrations and premenstrual symptomatology in women with a menstrually related mood disorder.

Authors:  Shannon K Crowley; Cort A Pedersen; Jane Leserman; Susan S Girdler
Journal:  Biol Psychol       Date:  2015-04-17       Impact factor: 3.251

Review 6.  Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction.

Authors:  Yael I Nillni; Donna J Toufexis; Kelly J Rohan
Journal:  Clin Psychol Rev       Date:  2011-07-26

7.  Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.

Authors:  C Neill Epperson; Benjamin Toll; Ran Wu; Zenab Amin; Kathryn A Czarkowski; Peter Jatlow; Carolyn M Mazure; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2010-06-19       Impact factor: 4.492

Review 8.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

9.  Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.

Authors:  Julia Potter; Jean Bouyer; James Trussell; Caroline Moreau
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

10.  The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO(2) challenge.

Authors:  Yael I Nillni; Kelly J Rohan; Michael J Zvolensky
Journal:  Arch Womens Ment Health       Date:  2012-08-25       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.